Compile Data Set for Download or QSAR
Report error Found 25 Enz. Inhib. hit(s) with all data for entry = 10385
TargetGTPase KRas [G12D,Q61H](Human)
Shy Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 485674BDBM485674(US10940139, Example 02900 | US11000515, Compound T...)
Affinity DataIC50: 3.00E+3nMAssay Description:The following method was developed as specific assay for KRas G12D mutant protein.Buffer-I: 50 mM Tris, pH 7.5 150 mM NaCl (optional) 1 mM MgCl2 1 mM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2022
Entry Details
US Patent

TargetGTPase KRas [G12D,Q61H](Human)
Shy Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 485677BDBM485677(US10940139, Example 02907 | US11000515, Compound T...)
Affinity DataIC50: 3.00E+3nMAssay Description:The following method was developed as specific assay for KRas G12D mutant protein.Buffer-I: 50 mM Tris, pH 7.5 150 mM NaCl (optional) 1 mM MgCl2 1 mM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2022
Entry Details
US Patent

TargetGTPase KRas [G12D,Q61H](Human)
Shy Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 485673BDBM485673(US10940139, Example 02899 | US11000515, Compound T...)
Affinity DataIC50: 3.00E+3nMAssay Description:The following method was developed as specific assay for KRas G12D mutant protein.Buffer-I: 50 mM Tris, pH 7.5 150 mM NaCl (optional) 1 mM MgCl2 1 mM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2022
Entry Details
US Patent

TargetGTPase KRas [G12D,Q61H](Human)
Shy Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 485653BDBM485653(US10940139, Example 02471 | US11000515, Compound T...)
Affinity DataIC50: 5.00E+3nMAssay Description:The following method was developed as specific assay for KRas G12D mutant protein.Buffer-I: 50 mM Tris, pH 7.5 150 mM NaCl (optional) 1 mM MgCl2 1 mM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2022
Entry Details
US Patent

TargetGTPase KRas [G12D,Q61H](Human)
Shy Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 485654BDBM485654(US10940139, Example 02511 | US11000515, Compound T...)
Affinity DataIC50: 5.00E+3nMAssay Description:The following method was developed as specific assay for KRas G12D mutant protein.Buffer-I: 50 mM Tris, pH 7.5 150 mM NaCl (optional) 1 mM MgCl2 1 mM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2022
Entry Details
US Patent

TargetGTPase KRas [G12D,Q61H](Human)
Shy Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 485657BDBM485657(US10940139, Example 02639 | US11000515, Compound T...)
Affinity DataIC50: 5.00E+3nMAssay Description:The following method was developed as specific assay for KRas G12D mutant protein.Buffer-I: 50 mM Tris, pH 7.5 150 mM NaCl (optional) 1 mM MgCl2 1 mM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2022
Entry Details
US Patent

TargetGTPase KRas [G12D,Q61H](Human)
Shy Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 485659BDBM485659(US10940139, Example 02680 | US11000515, Compound T...)
Affinity DataIC50: 7.50E+3nMAssay Description:The following method was developed as specific assay for KRas G12D mutant protein.Buffer-I: 50 mM Tris, pH 7.5 150 mM NaCl (optional) 1 mM MgCl2 1 mM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2022
Entry Details
US Patent

TargetGTPase KRas [G12D,Q61H](Human)
Shy Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 485658BDBM485658(US10940139, Example 02647 | US11000515, Compound T...)
Affinity DataIC50: 7.50E+3nMAssay Description:The following method was developed as specific assay for KRas G12D mutant protein.Buffer-I: 50 mM Tris, pH 7.5 150 mM NaCl (optional) 1 mM MgCl2 1 mM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2022
Entry Details
US Patent

TargetGTPase KRas [G12D,Q61H](Human)
Shy Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 485661BDBM485661(US10940139, Example 02708 | US11000515, Compound T...)
Affinity DataIC50: 7.50E+3nMAssay Description:The following method was developed as specific assay for KRas G12D mutant protein.Buffer-I: 50 mM Tris, pH 7.5 150 mM NaCl (optional) 1 mM MgCl2 1 mM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2022
Entry Details
US Patent

TargetGTPase KRas [G12D,Q61H](Human)
Shy Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 485663BDBM485663(US10940139, Example 02734 | US11000515, Compound T...)
Affinity DataIC50: 7.50E+3nMAssay Description:The following method was developed as specific assay for KRas G12D mutant protein.Buffer-I: 50 mM Tris, pH 7.5 150 mM NaCl (optional) 1 mM MgCl2 1 mM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2022
Entry Details
US Patent

TargetGTPase KRas [G12D,Q61H](Human)
Shy Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 485664BDBM485664(US10940139, Example 02761 | US11000515, Compound T...)
Affinity DataIC50: 7.50E+3nMAssay Description:The following method was developed as specific assay for KRas G12D mutant protein.Buffer-I: 50 mM Tris, pH 7.5 150 mM NaCl (optional) 1 mM MgCl2 1 mM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2022
Entry Details
US Patent

TargetGTPase KRas [G12D,Q61H](Human)
Shy Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 485666BDBM485666(US10940139, Example 02769 | US11000515, Compound T...)
Affinity DataIC50: 7.50E+3nMAssay Description:The following method was developed as specific assay for KRas G12D mutant protein.Buffer-I: 50 mM Tris, pH 7.5 150 mM NaCl (optional) 1 mM MgCl2 1 mM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2022
Entry Details
US Patent

TargetGTPase KRas [G12D,Q61H](Human)
Shy Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 485655BDBM485655(US10940139, Example 02555 | US11000515, Compound T...)
Affinity DataIC50: 7.50E+3nMAssay Description:The following method was developed as specific assay for KRas G12D mutant protein.Buffer-I: 50 mM Tris, pH 7.5 150 mM NaCl (optional) 1 mM MgCl2 1 mM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2022
Entry Details
US Patent

TargetGTPase KRas [G12D,Q61H](Human)
Shy Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 485672BDBM485672(US10940139, Example 02808 | US11000515, Compound T...)
Affinity DataIC50: 7.50E+3nMAssay Description:The following method was developed as specific assay for KRas G12D mutant protein.Buffer-I: 50 mM Tris, pH 7.5 150 mM NaCl (optional) 1 mM MgCl2 1 mM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2022
Entry Details
US Patent

TargetGTPase KRas [G12D,Q61H](Human)
Shy Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 485675BDBM485675(US10940139, Example 02901 | US11000515, Compound T...)
Affinity DataIC50: 2.05E+4nMAssay Description:The following method was developed as specific assay for KRas G12D mutant protein.Buffer-I: 50 mM Tris, pH 7.5 150 mM NaCl (optional) 1 mM MgCl2 1 mM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2022
Entry Details
US Patent

TargetGTPase KRas [G12D,Q61H](Human)
Shy Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 485676BDBM485676(US10940139, Example 02903 | US11000515, Compound T...)
Affinity DataIC50: 2.05E+4nMAssay Description:The following method was developed as specific assay for KRas G12D mutant protein.Buffer-I: 50 mM Tris, pH 7.5 150 mM NaCl (optional) 1 mM MgCl2 1 mM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2022
Entry Details
US Patent

TargetGTPase KRas [G12D,Q61H](Human)
Shy Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 485660BDBM485660(US10940139, Example 02704 | US11000515, Compound T...)
Affinity DataIC50: 2.05E+4nMAssay Description:The following method was developed as specific assay for KRas G12D mutant protein.Buffer-I: 50 mM Tris, pH 7.5 150 mM NaCl (optional) 1 mM MgCl2 1 mM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2022
Entry Details
US Patent

TargetGTPase KRas [G12D,Q61H](Human)
Shy Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 485662BDBM485662(US10940139, Example 02726 | US11000515, Compound T...)
Affinity DataIC50: 2.05E+4nMAssay Description:The following method was developed as specific assay for KRas G12D mutant protein.Buffer-I: 50 mM Tris, pH 7.5 150 mM NaCl (optional) 1 mM MgCl2 1 mM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2022
Entry Details
US Patent

TargetGTPase KRas [G12D,Q61H](Human)
Shy Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 485665BDBM485665(US10940139, Example 02767 | US11000515, Compound T...)
Affinity DataIC50: 2.05E+4nMAssay Description:The following method was developed as specific assay for KRas G12D mutant protein.Buffer-I: 50 mM Tris, pH 7.5 150 mM NaCl (optional) 1 mM MgCl2 1 mM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2022
Entry Details
US Patent

TargetGTPase KRas [G12D,Q61H](Human)
Shy Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 485667BDBM485667(US10940139, Example 02773 | US11000515, Compound T...)
Affinity DataIC50: 2.05E+4nMAssay Description:The following method was developed as specific assay for KRas G12D mutant protein.Buffer-I: 50 mM Tris, pH 7.5 150 mM NaCl (optional) 1 mM MgCl2 1 mM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2022
Entry Details
US Patent

TargetGTPase KRas [G12D,Q61H](Human)
Shy Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 485669BDBM485669(US10940139, Example 02800 | US11000515, Compound T...)
Affinity DataIC50: 2.05E+4nMAssay Description:The following method was developed as specific assay for KRas G12D mutant protein.Buffer-I: 50 mM Tris, pH 7.5 150 mM NaCl (optional) 1 mM MgCl2 1 mM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2022
Entry Details
US Patent

TargetGTPase KRas [G12D,Q61H](Human)
Shy Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 485668BDBM485668(US10940139, Example 02799 | US11000515, Compound T...)
Affinity DataIC50: 2.05E+4nMAssay Description:The following method was developed as specific assay for KRas G12D mutant protein.Buffer-I: 50 mM Tris, pH 7.5 150 mM NaCl (optional) 1 mM MgCl2 1 mM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2022
Entry Details
US Patent

TargetGTPase KRas [G12D,Q61H](Human)
Shy Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 485671BDBM485671(US10940139, Example 02804 | US11000515, Compound T...)
Affinity DataIC50: 2.05E+4nMAssay Description:The following method was developed as specific assay for KRas G12D mutant protein.Buffer-I: 50 mM Tris, pH 7.5 150 mM NaCl (optional) 1 mM MgCl2 1 mM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2022
Entry Details
US Patent

TargetGTPase KRas [G12D,Q61H](Human)
Shy Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 485670BDBM485670(US10940139, Example 02803 | US11000515, Compound T...)
Affinity DataIC50: 2.05E+4nMAssay Description:The following method was developed as specific assay for KRas G12D mutant protein.Buffer-I: 50 mM Tris, pH 7.5 150 mM NaCl (optional) 1 mM MgCl2 1 mM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2022
Entry Details
US Patent

TargetGTPase KRas [G12D,Q61H](Human)
Shy Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 485656BDBM485656(US10940139, Example 02592 | US11000515, Compound T...)
Affinity DataIC50: 2.05E+4nMAssay Description:The following method was developed as specific assay for KRas G12D mutant protein.Buffer-I: 50 mM Tris, pH 7.5 150 mM NaCl (optional) 1 mM MgCl2 1 mM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2022
Entry Details
US Patent